| PERIOD ENDING | 3-Sep-09 | 4-Jun-09 | 5-Mar-09 | 4-Dec-08 | | Total Revenue | 1,302,000 | 1,106,000 | 993,000 | 1,402,000 | | Cost of Revenue | 1,132,000 | 999,000 | 1,260,000 | 1,851,000 | | | Gross Profit | 170,000 | 107,000 | (267,000) | (449,000) | | | Operating Expenses | | Research Development | 139,000 | 162,000 | 168,000 | 178,000 | | Selling General and Administrative | (39,000) | 172,000 | 110,000 | 111,000 | | Non Recurring | 119,000 | 19,000 | 163,000 | (66,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (49,000) | (246,000) | (708,000) | (672,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 3,000 | 6,000 | (4,000) | | Earnings Before Interest And Taxes | (48,000) | (243,000) | (702,000) | (676,000) | | Interest Expense | 33,000 | 37,000 | 35,000 | 30,000 | | Income Before Tax | (81,000) | (280,000) | (737,000) | (706,000) | | Income Tax Expense | (13,000) | (2,000) | 30,000 | (13,000) | | Minority Interest | 14,000 | 33,000 | 77,000 | (13,000) | | | | Net Income From Continuing Ops | (88,000) | (290,000) | (751,000) | (706,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (88,000) | (290,000) | (751,000) | (706,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($88,000) | ($290,000) | ($751,000) | ($706,000) |
|
0.03% Nasdaq 0.00%
Income Statement
